REQUEST A DEMO
Total
USD $0.00
Search more companies

Zhejiang Tianyu Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Zhejiang Tianyu Pharmaceutical Co., Ltd. Profile Updated: June 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Zhejiang Tianyu Pharmaceutical Co., Ltd. is a pharmaceutical company located in Taizhou, China. It was established in 2003 and is a publicly traded company specializing in the research, development, manufacturing, and sales of formulations, active pharmaceutical ingredients, and pharmaceutical intermediates. The company has a registered capital of 347.977159 million yuan and owns eight wholly-owned subsidiaries. With over 5,000 employees, it occupies an area of over 700 acres. Zhejiang Tianyu Pharmaceutical Co., Ltd. is recognized as a national high-tech enterprise and a national intellectual property demonstration enterprise. The company's main products include pharmaceutical intermediates and active pharmaceutical ingredients in the areas of antihypertensive, antidiabetic, antithrombotic, anti-asthmatic, and antiviral drugs. It is one of the world's leading producers of losartan-based active pharmaceutical ingredients and intermediates. Over 50% of its products are supplied to internationally and domestically renowned pharmaceutical companies such as TEVA, POLPHARM, and NOVARTIS-SANDOZ. Zhejiang Tianyu Pharmaceutical Co., Ltd. holds a leading position among similar domestic manufacturers.

Headquarters
Huangyan Jiangkou Chemical Development Zone, Taizhou City, Zhejiang Province
Taizhou; Zhejiang; Postal Code: 318020

Contact Details: Purchase the Zhejiang Tianyu Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.tianyupharm.com

Basic Information
Total Employees:
Purchase the Zhejiang Tianyu Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Zhejiang Tianyu Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Zhejiang Tianyu Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Zhejiang Tianyu Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
February 14, 2003
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
35.07%
Purchase this report to view the information.
16.41%
Purchase this report to view the information.
6.19%
Purchase this report to view the information.
3.01%
Purchase this report to view the information.
1.05%
Subsidiaries
Binhai Sanyong Pharmaceutical Chemical Co., Ltd.
100%
Changyi Tianyu Pharmaceutical Co., Ltd.
100%
Hainan Weituo International Trade Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Zhejiang Tianyu Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-11.29%
Total operating revenue
-14.2%
Operating profit (EBIT)
-52.91%
EBITDA
-61.73%
Net Profit (Loss) for the Period
-59.58%
Total assets
-3.95%
Total equity
-2.76%
Operating Profit Margin (ROS)
-7.67%
Net Profit Margin
-7.02%
Return on Equity (ROE)
-1.62%
Debt to Equity Ratio
4.46%
Quick Ratio
-0.05%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?